Amphivena Therapeutics Is A Clinical Stage Immuno Oncology Company That Develops A Platform Of Dual Function Biologicsits Amphivena Restore Platform Provides Dual Action Biologics That Relieve Immune Suppression And Activate T Cell Effector Function In Cancer Patientsthe Platform Design Integrates Elements Of Aviditytarget Selectivityandenhanced Safety Within A Single Moleculeit Is Also Can Be Engineered With Additional Solid Tumor Targeting Modalities To Add Functionality Such As Directed Tumor Cell Killing It Was Founded In 2012 And Is Headquartered In South San Franciscocalifornia
